title: Efavirenz decreases methadone blood concentrations.
authors.forename: C
authors.initials: C
authors.lastname: Marzolini
authors.forename: N
authors.initials: N
authors.lastname: Troillet
authors.forename: A
authors.initials: A
authors.lastname: Telenti
authors.forename: P
authors.initials: P
authors.lastname: Baumann
authors.forename: L A
authors.initials: LA
authors.lastname: Decosterd
authors.forename: C B
authors.initials: CB
authors.lastname: Eap
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D003521:Cyclopropanes; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008691:Methadone / Q000097:blood* / Q000493:pharmacokinetics; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018119:Stavudine / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine; C098320:efavirenz; D008691:Methadone